Position in YCBD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$0
-$1 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in YCBD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $133,569,034 across 49 Drug Manufacturers - Specialty & Generic names. YCBD ranks #49 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
5,103,509 | $51,086,123 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
282,097 | $37,163,457 | |
| 3 | ZTS |
Zoetis Inc.
|
253,206 | $29,931,479 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
173,438 | $8,351,039 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
64,920 | $1,553,534 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,562 | $926,232 | |
| 7 | VTRS |
Viatris Inc
|
59,826 | $808,247 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
47,612 | $659,425 |
All Filings in YCBD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0 | 1 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1 | 1 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $1 | 1 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||